Research and Development Center, Olimp Laboratories Sp. z o.o, Pustynia 84F, 39-200 Dębica, Poland.
Nutrients. 2022 Sep 24;14(19):3967. doi: 10.3390/nu14193967.
Herein we gathered updated knowledge regarding the alterations of gut microbiota (dysbiosis) and its correlation with human neurodegenerative and brain-related diseases, e.g., Alzheimer's and Parkinson's. This review underlines the importance of gut-derived metabolites and gut metabolic status as the main players in gut-brain crosstalk and their implications on the severity of neural conditions. Scientific evidence indicates that the administration of probiotic bacteria exerts beneficial and protective effects as reduced systemic inflammation, neuroinflammation, and inhibited neurodegeneration. The experimental results performed on animals, but also human clinical trials, show the importance of designing a novel microbiota-based probiotic dietary supplementation with the aim to prevent or ease the symptoms of Alzheimer's and Parkinson's diseases or other forms of dementia or neurodegeneration.
在此,我们收集了有关肠道微生物群(失调)改变及其与人类神经退行性和脑部相关疾病(如阿尔茨海默病和帕金森病)相关性的最新知识。本综述强调了肠道衍生代谢物和肠道代谢状态作为肠道-大脑相互作用的主要参与者的重要性,以及它们对神经状况严重程度的影响。科学证据表明,益生菌的给药具有有益和保护作用,可减少全身炎症、神经炎症和抑制神经退行性变。在动物身上进行的实验结果,以及人体临床试验,都表明设计一种基于微生物组的新型益生菌饮食补充剂的重要性,旨在预防或缓解阿尔茨海默病和帕金森病或其他形式的痴呆或神经退行性变的症状。